AAAAAA

   
Results: 1-18 |
Results: 18
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
Authors: Broderick, J Lu, M Jackson, C Pancioli, A Tilley, BC Fagan, SC Kothari, R Levine, SR Marler, JR Lyden, PD Haley, EC Brott, T Grotta, JC
Citation: J. Broderick et al., Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke, ANN NEUROL, 49(6), 2001, pp. 736-744
Angiogenesis after stroke is correlated with increased numbers of macrophages: The clean-up hypothesis
Authors: Manoonkitiwongsa, PS Jackson-Friedman, C McMillan, PJ Schultz, RL Lyden, PD
Citation: Ps. Manoonkitiwongsa et al., Angiogenesis after stroke is correlated with increased numbers of macrophages: The clean-up hypothesis, J CEREBR B, 21(10), 2001, pp. 1223-1231
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke
Authors: Patel, SC Levine, SR Tilley, BC Grotta, JC Lu, M Frankel, M Haley, EC Brott, TG Broderick, JP Horowitz, S Lyden, PD Lewandowski, CA Marler, JR Welch, KMA
Citation: Sc. Patel et al., Lack of clinical significance of early ischemic changes on computed tomography in acute stroke, J AM MED A, 286(22), 2001, pp. 2830-2838
Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II)
Authors: Albers, GW Bogousslavsky, J Bozik, MA Brass, LM Broderick, JP Fisher, M Goldstein, LB Salazar-Grueso, E Akitsuki, S Aranko, K Ashwood, T Atkinson, RP Bell, RD Brott, TG Cady, WJ Caplan, LR Coggins, S Cramer, S Cyrus, P Dayno, J Easton, JD Elliott, PJ Finklestein, SP Furlan, AJ Gamzu, E Glasky, MS Gordon, K Gorelick, PB Greenwood, DT Grotta, JC Gunn, K Hachinski, V Hacke, W Hall, ED Hsu, CY Humphreys, DM Ishikawa, H Jacobs, AJ Kaste, M Koroshetz, WJ Krams, M Lauritano, AA Leclerc, J Lees, KR Lesko, L Levine, SR Levy, DE Li, FH Lyden, PD Masayasu, H McDermott, J Meibach, RC Meya, U Miyairi, K Niidome, T Oeda, J Poole, RM Ron, ES Sacco, RL Saltarelli, MD Shimizu, K Shook, BJ Soehngen, M Soehngen, W Stamler, DA Styren, SD Teal, PA Tilley, BC Traystman, RJ Walker, MD Wallin, BA Warach, S Ward, DP Wessel, TC Wettstein, J
Citation: Gw. Albers et al., Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II), STROKE, 32(7), 2001, pp. 1598-1606
A modified National Institutes of Health Stroke Scale for use in stroke clinical trials - Preliminary reliability and validity
Authors: Lyden, PD Lu, M Levine, SR Brott, TG Broderick, J
Citation: Pd. Lyden et al., A modified National Institutes of Health Stroke Scale for use in stroke clinical trials - Preliminary reliability and validity, STROKE, 32(6), 2001, pp. 1310-1316
Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial
Authors: Grotta, JC Welch, KMA Fagan, SC Lu, M Frankel, MR Brott, T Levine, SR Lyden, PD
Citation: Jc. Grotta et al., Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial, STROKE, 32(3), 2001, pp. 661-668
Further randomized controlled trials of tPA within 3 hours are required - NOT!
Authors: Lyden, PD
Citation: Pd. Lyden, Further randomized controlled trials of tPA within 3 hours are required - NOT!, STROKE, 32(11), 2001, pp. 2709-2710
The ischemic penumbra and neuronal salvage
Authors: Lyden, PD
Citation: Pd. Lyden, The ischemic penumbra and neuronal salvage, THROMBOLYTIC THERAPY FOR STROKE, 2001, pp. 43-62
The case for thrombolytic therapy in stroke patients
Authors: Lyden, PD
Citation: Pd. Lyden, The case for thrombolytic therapy in stroke patients, THROMBOLYTIC THERAPY FOR STROKE, 2001, pp. 211-221
The NINDS t-PA for acute stroke protocol
Authors: Marler, J Lyden, PD
Citation: J. Marler et Pd. Lyden, The NINDS t-PA for acute stroke protocol, THROMBOLYTIC THERAPY FOR STROKE, 2001, pp. 297-308
Stroke prevention and acute intervention: Review of recent advances
Authors: Brockington, CD Lyden, PD
Citation: Cd. Brockington et Pd. Lyden, Stroke prevention and acute intervention: Review of recent advances, FORMULARY, 35(4), 2000, pp. 328
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA Stroke Trial
Authors: Broderick, JP Lu, M Kothari, R Levine, SR Lyden, PD Haley, EC Brott, TG Grotta, J Tilley, BC Marler, JR Frankel, M
Citation: Jp. Broderick et al., Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA Stroke Trial, STROKE, 31(10), 2000, pp. 2335-2341
Synergistic combinatorial stroke therapy: A quantal bioassay of a GABA agonist and a glutamate antagonist
Authors: Lyden, PD Jackson-Friedman, C Shin, C Hassid, S
Citation: Pd. Lyden et al., Synergistic combinatorial stroke therapy: A quantal bioassay of a GABA agonist and a glutamate antagonist, EXP NEUROL, 163(2), 2000, pp. 477-489
Criteria for selection of older patients for thrombolytic therapy
Authors: Brockington, CD Lyden, PD
Citation: Cd. Brockington et Pd. Lyden, Criteria for selection of older patients for thrombolytic therapy, CLIN GERIAT, 15(4), 1999, pp. 721
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy
Authors: Grotta, JC Chin, D Lu, M Patel, S Levine, SR Tilley, BC Brott, TG Haley, EC Lyden, PD Kothari, R Frankel, M Lewandowski, CA Libman, R Kwiatkowski, T Broderick, JP Marler, JR Corrigan, J Huff, S Mitsias, P Talati, S Tanne, D
Citation: Jc. Grotta et al., Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy, STROKE, 30(8), 1999, pp. 1528-1533
Does the National Institutes of Health Stroke Scale favor left hemisphere strokes?
Authors: Woo, D Broderick, JP Kothari, RU Lu, M Brott, T Lyden, PD Marler, JR Grotta, JC
Citation: D. Woo et al., Does the National Institutes of Health Stroke Scale favor left hemisphere strokes?, STROKE, 30(11), 1999, pp. 2355-2359
Thrombolysis for acute stroke
Authors: Lyden, PD
Citation: Pd. Lyden, Thrombolysis for acute stroke, PROG CARD, 42(3), 1999, pp. 175-183
gamma-aminobutyric acid agonists for neuroprotection
Authors: Lyden, PD
Citation: Pd. Lyden, gamma-aminobutyric acid agonists for neuroprotection, STROKE THERAPY, 1999, pp. 101-130
Risultati: 1-18 |